RDNT on Nasdaq
RadNet, Inc.
We are a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue.3 From its latest annual report
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Natera, Fortrea Holdings Inc. or Exact Sciences, or pick any stock.
- TickerRDNT on Nasdaq1
- IndustryServices-Medical Laboratories1
- HeadquartersLos Angeles, California1
- Incorporated inDE2
- Business address1510 Cotner Ave, Los Angeles, Ca 900252
- Filer categoryLarge accelerated filer2
See how the biggest companies compare on our leaderboards
We are a leading national provider of diagnostic imaging services in the United States based on number of locations and annual imaging revenue. We have been in business since 1985. Our principal business segment is the provision of diagnostic imaging services. As of December 31, 2025, we operated, directly or indirectly through hospital and health system joint ventures, 418 imaging centers located in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas and New York.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Commercial Insurance1 brought in 55% of the revenue RadNet, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Commercial Insurance1 | $879.8M | $1.0B | $1.1B |
| Medicare1 | $356.5M | $410.1M | $477.0M |
| Capitation Arrangements | $153.4M | $136.6M | $125.5M |
| Other Payors | $87.7M | $104.9M | $118.6M |
| Health Care, Other | $32.6M | $46.7M | $65.0M |
| Medicaid1 | $42.3M | $44.7M | $51.7M |
| Workers' Compensation/Personal Injury1 | $46.4M | $43.7M | $44.7M |
| Health Care, Management Service | $17.9M | $24.7M | $27.5M |
Business segments
Imaging Centers brought in 96% of the revenue RadNet, Inc. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Imaging Centers | $1.6B | $1.8B | $2.0B |
| Digital Health | $49.6M | $65.7M | $92.7M |
Regions
United States brought in 98% of the revenue RadNet, Inc. broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $1.6B | $1.8B | $2.0B |
| Outside the United States | $16.9M | $27.2M | $34.0M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs99¢$2.0B
- Income tax1¢$14.9M
Out of $2.0B in revenue.4 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Kept or used elsewhere100¢$298.8M
Out of $298.8M of cash from operations.4
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total service revenue | $2.0B | $1.8B | $1.6B |
| Cost of operations, excluding depreciation and amortization | $1.8B | $1.6B | $1.4B |
| Lease abandonment charges | $8.6M | $2.5M | $5.1M |
| Depreciation and amortization | $152.1M | $137.8M | $128.4M |
| Gain on contribution of imaging centers into joint venture | $0 | $0 | -$16.8M |
| Loss on sale and disposal of equipment | $9.7M | $2.3M | $2.2M |
| Severance costs | $3.1M | $1.9M | $3.8M |
| Total operating expenses | $2.0B | $1.7B | $1.5B |
| INCOME FROM OPERATIONS | $62.0M | $104.6M | $98.7M |
| Interest expense | $69.9M | $79.8M | $64.5M |
| Equity in earnings of joint ventures | -$14.9M | -$14.5M | -$6.4M |
| Non-cash change in fair value of interest rate swaps | $7.1M | $8.0M | $8.2M |
| Debt restructuring and extinguishment expenses | $0 | $11.3M | $0 |
| Other income | -$32.1M | -$24.9M | -$6.4M |
| Total other expenses | $30.1M | $59.8M | $59.9M |
| Income before income taxes | $31.9M | $44.9M | $38.8M |
| Provision for income taxes | -$14.9M | -$6.0M | -$8.5M |
| NET INCOME | $17.0M | $38.8M | $30.3M |
| Net income attributable to noncontrolling interest | $35.7M | $36.0M | $27.3M |
| NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS | -$18.7M | $2.8M | $3.0M |
| BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share) | -$0.25 | $0.04 | $0.05 |
| DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share) | -$0.25 | $0.04 | $0.05 |
| Basic (in shares) | 75.2M shares | 73.0M shares | 63.6M shares |
| Diluted (in shares) | 75.2M shares | 74.8M shares | 64.7M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $767.2M | $740.0M | ||
| Accounts receivable, net | $200.3M | $185.8M | ||
| Prepaid expenses and other current assets | $52.0M | $51.5M | ||
| Total current assets | $1.0B | $1.0B | ||
| Property and equipment, net | $807.7M | $694.8M | ||
| Operating lease right-of-use assets | $690.2M | $639.7M | ||
| Total property, equipment and right-of-use assets | $1.5B | $1.3B | ||
| Goodwill | $907.7M | $710.7M | $679.5M | |
| Other intangible assets | $148.5M | $81.4M | ||
| Deferred financing costs | $1.7M | $2.3M | ||
| Investment in joint ventures | $130.3M | $104.1M | $92.7M | |
| Deposits and other | $40.3M | $34.6M | ||
| Total assets | $3.8B | $3.3B | ||
| Accounts payable, accrued expenses and other | $422.0M | $351.5M | ||
| Deferred revenue | $7.3M | $3.3M | ||
| Current portion of operating lease liability | $61.9M | $56.6M | ||
| Current portion of notes payable | $25.4M | $24.7M | ||
| Total current liabilities | $586.8M | $479.7M | ||
| Long-term operating lease liability | $707.0M | $656.0M | ||
| Notes payable, net of current portion | $1.1B | $991.6M | ||
| Deferred tax liability, net | $21.9M | $22.2M | ||
| Other non-current liabilities | $22.5M | $3.8M | ||
| Total liabilities | $2.4B | $2.2B | ||
| Common stock - $.0001 par value, 200,000,000 shares authorized; 77,399,615 and 74,036,993 shares issued and outstanding at December 31, 2025 and 2024 respectively | $8.0K | $7.0K | ||
| Additional paid-in-capital | $1.2B | $988.1M | ||
| Accumulated other comprehensive income (loss) | $4.9M | -$9.1M | ||
| Accumulated deficit | -$95.4M | -$76.8M | ||
| Total RadNet, Inc.'s stockholders' equity | $1.1B | $902.3M | ||
| Noncontrolling interests | $266.0M | $231.1M | ||
| Total equity | $1.4B | $1.1B | $813.4M | $491.5M |
| Total liabilities and equity | $3.8B | $3.3B | ||
| Common stock - par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock - authorized (in shares) | 200.0M shares | 200.0M shares | ||
| Common stock - issued (in shares) | 77.4M shares | 77.4M shares | ||
| Common stock - outstanding (in shares) | 74.0M shares | 74.0M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $767.2M | $740.0M | ||
| Accounts receivable, net | $200.3M | $185.8M | ||
| Prepaid expenses and other current assets | $52.0M | $51.5M | ||
| Total current assets | $1.0B | $1.0B | ||
| Property and equipment, net | $807.7M | $694.8M | ||
| Operating lease right-of-use assets | $690.2M | $639.7M | ||
| Total property, equipment and right-of-use assets | $1.5B | $1.3B | ||
| Goodwill | $907.7M | $710.7M | $679.5M | |
| Other intangible assets | $148.5M | $81.4M | ||
| Deferred financing costs | $1.7M | $2.3M | ||
| Investment in joint ventures | $130.3M | $104.1M | $92.7M | |
| Deposits and other | $40.3M | $34.6M | ||
| Total assets | $3.8B | $3.3B | ||
| Accounts payable, accrued expenses and other | $422.0M | $351.5M | ||
| Deferred revenue | $7.3M | $3.3M | ||
| Current portion of operating lease liability | $61.9M | $56.6M | ||
| Current portion of notes payable | $25.4M | $24.7M | ||
| Total current liabilities | $586.8M | $479.7M | ||
| Long-term operating lease liability | $707.0M | $656.0M | ||
| Notes payable, net of current portion | $1.1B | $991.6M | ||
| Deferred tax liability, net | $21.9M | $22.2M | ||
| Other non-current liabilities | $22.5M | $3.8M | ||
| Total liabilities | $2.4B | $2.2B | ||
| Common stock - $.0001 par value, 200,000,000 shares authorized; 77,399,615 and 74,036,993 shares issued and outstanding at December 31, 2025 and 2024 respectively | $8.0K | $7.0K | ||
| Additional paid-in-capital | $1.2B | $988.1M | ||
| Accumulated other comprehensive income (loss) | $4.9M | -$9.1M | ||
| Accumulated deficit | -$95.4M | -$76.8M | ||
| Total RadNet, Inc.'s stockholders' equity | $1.1B | $902.3M | ||
| Noncontrolling interests | $266.0M | $231.1M | ||
| Total equity | $1.4B | $1.1B | $813.4M | $491.5M |
| Total liabilities and equity | $3.8B | $3.3B | ||
| Common stock - par value (in dollars per share) | $0.00 | $0.00 | ||
| Common stock - authorized (in shares) | 200.0M shares | 200.0M shares | ||
| Common stock - issued (in shares) | 77.4M shares | 77.4M shares | ||
| Common stock - outstanding (in shares) | 74.0M shares | 74.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net (loss) income | $17.0M | $38.8M | $30.3M |
| Depreciation and amortization | $152.1M | $137.8M | $128.4M |
| Non-cash lease expense | $59.9M | $60.6M | $61.1M |
| Equity in earnings of joint ventures, net of dividend | -$5.8M | -$9.9M | $9.2M |
| Amortization of deferred financing costs and loan discount | $3.0M | $3.1M | $3.0M |
| Loss on sale and disposal of equipment | $9.7M | $2.3M | $2.2M |
| Loss on extinguishment of debt | $0 | $3.9M | $0 |
| Gain on contribution of imaging centers into joint venture | $0 | $0 | -$16.8M |
| Lease abandonment charges | $8.6M | $2.5M | $5.1M |
| Amortization of cash flow hedge | $2.3M | $9.4M | $3.6M |
| Non-cash change in fair value of interest rate swaps | $7.1M | $8.0M | $8.2M |
| Stock-based compensation | $54.6M | $29.8M | $26.8M |
| Loss on impairment | $0 | $1.3M | $3.9M |
| Change in fair value of contingent consideration | $111.0K | $2.0M | -$3.9M |
| Accounts receivable | -$9.6M | -$21.8M | $2.6M |
| Other current assets | $2.3M | -$32.8M | -$8.4M |
| Other assets | -$5.7M | $10.7M | -$1.5M |
| Deferred taxes | $10.8M | $6.5M | $6.1M |
| Operating lease liability | -$62.8M | -$54.9M | -$54.8M |
| Deferred revenue | $2.8M | -$1.4M | $626.0K |
| Accounts payable, accrued expenses and other | $52.4M | $37.1M | $15.1M |
| Net cash provided by operating activities | $298.8M | $233.0M | $220.9M |
| Purchase of imaging facilities and other acquisitions, net of cash acquired | -$133.4M | -$43.7M | -$10.9M |
| Purchase of property and equipment | -$213.3M | -$188.1M | -$176.6M |
| Proceeds from sale of equipment | $1.3M | $157.0K | $83.0K |
| Equity Contributions In Joint Ventures | -$4.1M | -$1.5M | -$14.0M |
| Collection of notes receivable | $5.7M | $0 | $0 |
| Net cash used in investing activities | -$343.9M | -$233.1M | -$201.5M |
| Principal payments on notes and leases payable | -$7.0M | -$6.0M | -$2.9M |
| Payments on term loan debt | -$20.8M | -$692.4M | -$41.1M |
| Proceeds from issuance of debt, net of issuance costs | $99.0M | $863.8M | $0 |
| Sale of noncontrolling interests | $2.4M | $22.4M | $5.1M |
| Payments of contingent consideration and holdbacks | -$2.2M | -$4.3M | -$5.5M |
| Distributions paid to noncontrolling interests | -$4.6M | -$4.5M | -$6.0M |
| Proceeds from issuance of common stock | $0 | $218.4M | $245.8M |
| Proceeds from issuance of common stock upon exercise of options | $5.4M | $667.0K | $142.0K |
| Net cash provided by financing activities | $72.2M | $397.9M | $195.6M |
| EFFECT OF EXCHANGE RATE CHANGES ON CASH | $33.0K | -$453.0K | -$292.0K |
| NET INCREASE IN CASH AND CASH EQUIVALENTS | $27.2M | $397.4M | $214.7M |
| Cash paid during the period for interest | $72.3M | $84.6M | $64.7M |
| Equipment acquired and leasehold improvements | $91.9M | $65.6M | $67.7M |
| Deemed contribution to joint venture | $16.3M |
No quarter-by-quarter statement was filed.
Leadership
Who has led RadNet, Inc., and when. Pick a name to see everywhere that person has worked.
Chief financial officer
Chief operating officer
- Chief executive officerStephen M. Forthuber Jun 16, 2026 to now13
- Chief executive officerCornelis Wesdorp Oct 2, 2024 to Jun 16, 202614
- Chief executive officerHoward G. Berger Jan 5, 2023 to Oct 2, 202415
- PresidentNorman R. Hames Jan 2, 2018 to Apr 5, 202116
- PresidentStephen M. Forthuber Jan 2, 2018 to Jan 10, 202017
- PresidentHoward G. Berger Feb 5, 2010 to Jan 2, 201818
- Chief financial officerStephen M. Forthuber Oct 30, 2008 to Oct 30, 200819
- Chief financial officerMark Stolper Jul 12, 2006 to Oct 30, 200820
- Chief operating officerNorman R. Hames Jan 6, 2021 to now21
- Chief operating officerStephen M. Forthuber Jan 6, 2021 to now22
Board members and other officers (26)
- EVP Chief Science OfficerAlma Gregory Sorenson Aug 18, 2023 to now23
- Chief Information OfficerRanjan Jayanathan Jan 19, 2021 to now24
- Senior Vice PresidentRuth Louisa Villigerwilson Feb 3, 2020 to Jan 6, 202225
- Executive Vice PresidentMital Patel Dec 15, 2016 to now26
- EVP, Hospital Based OperationsTodd W. Skulte Dec 3, 2014 to Jun 16, 201527
- VP Materials ManagementDerek Bomar Dec 9, 2014 to Jul 30, 201528
- Executive Vice PresidentMichael N. Murdock Jan 11, 2011 to now29
- Medical DirectorJohn Crues V. Jun 17, 2009 to Jun 14, 202130
- Executive Vice PresidentStephen M. Forthuber Apr 4, 2007 to Sep 24, 202131
- Vice PresidentJeffrey L. Linden Apr 10, 2006 to Sep 17, 201832
- Vice PresidentNorman R. Hames Apr 21, 2006 to Sep 24, 202133
- Vice chairSami S. Abbasi Nov 21, 2006 to Nov 30, 200634
- Board memberAlma Gregory Sorenson Aug 18, 2023 to now23
- Board memberChristine Nayoma Gordon Jun 14, 2021 to Jun 11, 202435
- Board memberGregory E. Spurlock Jun 14, 2021 to now36
- Board memberRuth Louisa Villigerwilson Feb 3, 2020 to Mar 6, 202325
- Board memberLaura Pastre Jacobs Jun 3, 2020 to now37
- Board memberMital Patel Jan 9, 2017 to Jan 9, 201738
- Board memberHoward G. Berger Feb 5, 2010 to now18
- Board memberMarvin S. Cadwell Mar 1, 2007 to Jun 18, 201939
- Board memberMichael L. Sherman Md. Mar 1, 2007 to Aug 21, 201940
- Board memberDavid L. Swartz Mar 29, 2006 to now41
- Board memberLawrence L. Levitt Mar 29, 2006 to now42
- Board memberNorman R. Hames Apr 21, 2006 to Apr 5, 202133
- Board memberJohn Crues V. Jul 18, 2006 to Jun 14, 202143
- Board memberSami S. Abbasi Nov 21, 2006 to Nov 21, 200634
Former names
- PRIMEDEX HEALTH SYSTEMS INCNov 1, 1996 to Nov 21, 20062
Timeline
Filings
372 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 51 major events, 175 insider forms, 19 large holders, 106 other. The latest 20:
- Aug 14, 20268-K CURRENT REPORT EDGAR
- Aug 14, 2026424B7 PROSPECTUS EDGAR
- Aug 14, 2026SCHEDULE 13G/A EDGAR
- Aug 10, 20268-K EDGAR
- Aug 10, 202610-Q EDGAR
- Jun 22, 20264 EDGAR
- Jun 18, 2026144 EDGAR
- Jun 18, 20264 EDGAR
- Jun 18, 20264 EDGAR
- Jun 16, 2026144 EDGAR
- Jun 16, 20264 EDGAR
- Jun 15, 2026144 EDGAR
- Jun 10, 20268-K EDGAR
- Jun 4, 20268-K CURRENT REPORT EDGAR
- Jun 3, 20264 EDGAR
- Jun 3, 20264 EDGAR
- Jun 3, 20264 EDGAR
- Jun 3, 20264 EDGAR
- Jun 3, 20268-K CURRENT REPORT EDGAR
- May 15, 2026SCHEDULE 13G EDGAR
The 372 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
73 open-market trades by officers, directors and large owners since October 2021: 0 buys and 73 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | SWARTZ DAVID LDirector | Sale | 2,699 | $53.89 | $145.4K | Form 4 |
| Jun 16, 2026 | Wesdorp CornelisPres & CEO, Digital Health | Sale | 4,750 | $58.11 | $276.0K | Form 4 |
| Jun 15, 2026 | Forthuber Stephen MPres & CEO-Eastern Operations | Sale | 44,067 | $58.16 | $2.6M | Form 4 |
| Mar 19, 2026 | Sorensen Alma GregoryChief Strategy Officer | Sale | 15,000 | $62.20 | $933.0K | Form 4 |
| Mar 18, 2026 | Sorensen Alma GregoryChief Strategy Officer | Sale | 15,000 | $62.15 | $932.3K | Form 4 |
| Dec 5, 2025 | Forthuber Stephen MPres & CEO-Eastern Operations | Sale | 45,088 | $78.33 | $3.5M | Form 4 |
| Nov 19, 2025 | Patel MitalEVP of Fin Planning, CAO | Sale | 15,080 | $80.05 | $1.2M | Form 4 |
| Nov 18, 2025 | Patel MitalEVP of Fin Planning, CAO | Sale | 9,920 | $80.00 | $793.6K | Form 4 |
| Nov 17, 2025 | Patel MitalEVP of Fin Planning, CAO | Sale | 25,000 | $76.06 | $1.9M | Form 4 |
| Sep 16, 2025 | STOLPER MARKEVP, Chief Financial Officer | Sale | 35,000 | $73.89 | $2.6M | Form 4 |
| Sep 16, 2025 | Katz David JeffreyEVP and Chief Legal Officer | Sale | 14,000 | $74.44 | $1.0M | Form 4 |
| Sep 11, 2025 | Wesdorp CornelisPres & CEO, Digital Health | Sale | 500 | $72.13 | $36.1K | Form 4 |
| Sep 10, 2025 | HAMES NORMAN RPres and COO-West Operations | Sale | 10,000 | $72.74 | $727.4K | Form 4 |
| Sep 9, 2025 | Wesdorp CornelisPres & CEO, Digital Health | Sale | 500 | $71.99 | $36.0K | Form 4 |
| Aug 27, 2025 | HAMES NORMAN RPres and COO-West Operations | Sale | 5,000 | $71.10 | $355.5K | Form 4 |
| Aug 19, 2025 | Wesdorp CornelisPres & CEO, Digital Health | Sale | 1,500 | $66.98 | $100.5K | Form 4 |
| Aug 19, 2025 | Jayanathan RanjanChief Information Officer | Sale | 65,598 | $67.50 | $4.4M | Form 4 |
| Aug 13, 2025 | Katz David JeffreyEVP and Chief Legal Officer | Sale | 17,000 | $68.31 | $1.2M | Form 4 |
| Jun 5, 2025 | Murdock Michael NEVP, Mergers and Acquisitions | Sale | 11,132 | $58.05 | $646.2K | Form 4 |
| May 23, 2025 | Sorensen Alma GregoryChief Strategy Officer | Sale | 55,000 | $56.48 | $3.1M | Form 4 |
All 73 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- RTW INVESTMENTS, LPSCHEDULE 13G/A, 2 filings Feb 17, 2026 to Aug 14, 202644
- PRICE T ROWE ASSOCIATES INC /MD/SCHEDULE 13G, 1 filing May 15, 202645
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202646
- VANGUARD GROUP INCSCHEDULE 13G/A, 7 filings Feb 10, 2022 to Mar 27, 202647
- BlackRockSCHEDULE 13G/A, 1 filing Oct 17, 202548
- Sandy Nyholm KaminskySC 13G/A, 1 filing Oct 24, 202449
- BECK MACK & OLIVER LLCSC 13G/A, 2 filings Feb 8, 2023 to Feb 14, 202450
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 10,957,808 | $675.8M | 0.0% | +922,074 |
| Rtw Investments, LP | 4,846,958 | $298.9M | 2.6% | +561,958 |
| Vanguard Portfolio Management LLC | 4,066,931 | $250.8M | 0.0% | +167,804 |
| Vanguard Capital Management LLC | 3,193,565 | $196.9M | 0.0% | +82,553 |
| Beck Mack & Oliver LLC | 3,163,592 | $195.1M | 3.8% | −2,600 |
| State Street Corp | 2,842,457 | $175.2M | 0.0% | +190,859 |
| Geode Capital Management, LLC | 1,858,508 | $114.6M | 0.0% | +134,901 |
| Invesco Ltd. | 1,641,292 | $101.2M | 0.0% | +7,797 |
| American Century Companies Inc | 1,618,424 | $99.8M | 0.0% | +716,232 |
| Clearbridge Investments, LLC | 1,546,652 | $95.4M | 0.1% | +268,112 |
| Dimensional Fund Advisors LP | 1,491,040 | $91.9M | 0.0% | +112,037 |
| Hood River Capital Management LLC | 1,456,205 | $89.8M | 0.7% | +44,708 |
| Jb Capital Partners LP | 1,424,061 | $87.8M | 13.6% | No change |
| Bamco Inc /ny/ | 1,260,992 | $77.8M | 0.1% | +450,926 |
| Defiance ETFs, LLC | 1,143,622 | $75.0M | 1.0% | +598,148 |
| Goldman Sachs Group Inc | 1,178,372 | $72.7M | 0.0% | −11,903 |
| Alyeska Investment Group, L.P. | 1,171,721 | $72.3M | 0.2% | −137,587 |
| Principal Financial Group Inc | 1,052,356 | $64.9M | 0.0% | −58,921 |
| Westfield Capital Management Co LP | 975,542 | $60.2M | 0.2% | +443,649 |
| Morgan Stanley | 931,114 | $57.4M | 0.0% | +80,643 |
| Northern Trust Corp | 813,056 | $50.1M | 0.0% | +66,249 |
| Charles Schwab Investment Management Inc | 792,282 | $48.9M | 0.0% | +24,811 |
| Rockefeller Capital Management L.P. | 757,990 | $46.7M | 0.1% | +54,874 |
| Ameriprise Financial Inc | 745,603 | $46.0M | 0.0% | −153,523 |
| Global Alpha Capital Management Ltd. | 734,875 | $45.3M | 2.7% | +76,667 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRadNet, Inc. filings on SEC EDGAR
- 2SEC EDGARRadNet, Inc. filings on SEC EDGAR
- 3
- 4SEC EDGARRadNet, Inc. 10-K for fiscal 2025
- 5SEC EDGARRadNet, Inc. 10-K for fiscal 2019
- 6SEC EDGARRadNet, Inc. 10-K for fiscal 2020
- 7SEC EDGARRadNet, Inc. 10-K for fiscal 2021
- 8SEC EDGARRadNet, Inc. 10-K for fiscal 2022
- 9SEC EDGARRadNet, Inc. 10-Q for fiscal 2026
- 10SEC EDGARRadNet, Inc. 10-Q for fiscal 2026
- 11SEC EDGARRadNet, Inc. 10-K for fiscal 2019
- 12SEC EDGARRadNet, Inc. 10-K for fiscal 2019
- 13
- 14
- 15
- 16SEC EDGARNorman R. Hames, President
- 17SEC EDGARStephen M. Forthuber, President
- 18SEC EDGARHoward G. Berger, President
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28SEC EDGARDerek Bomar, VP Materials Management
- 29
- 30SEC EDGARJohn Crues V., Medical Director
- 31
- 32SEC EDGARJeffrey L. Linden, Vice President
- 33SEC EDGARNorman R. Hames, Vice President
- 34SEC EDGARSami S. Abbasi, Vice chair
- 35
- 36SEC EDGARGregory E. Spurlock, Board member
- 37SEC EDGARLaura Pastre Jacobs, Board member
- 38SEC EDGARMital Patel, Board member
- 39SEC EDGARMarvin S. Cadwell, Board member
- 40SEC EDGARMichael L. Sherman Md., Board member
- 41SEC EDGARDavid L. Swartz, Board member
- 42SEC EDGARLawrence L. Levitt, Board member
- 43SEC EDGARJohn Crues V., Board member
- 44
- 45
- 46
- 47
- 48
- 49
- 50